Actuate Therapeutics Inc
ACTU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,407 | -$5,949 | -$6,317 | -$6,446 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,801 | $0 | $1,125 | $0 |
| Change in WC | -$3,076 | $191 | $568 | $477 |
| Other Non-Cash | $5 | $1,409 | $5 | $1,197 |
| Operating Cash Flow | -$6,678 | -$4,349 | -$4,619 | -$4,772 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $17,208 | $6,952 | -$133 | -$109 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$98 | $0 | $0 | $0 |
| Financing Cash Flow | $17,110 | $6,952 | -$133 | -$109 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10,432 | $2,603 | -$4,752 | -$4,882 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,493 | $3,889 | $8,642 | $13,523 |
| End Cash | $16,925 | $6,493 | $3,889 | $8,642 |
| Free Cash Flow | -$6,678 | -$4,349 | -$4,619 | -$4,772 |